GlassScriptPhysician profile
Harpreet Sheller
NPI 1407426695
$1,882.41
in general payments reported to CMS, 2019-2025
18 companies · $746 in 2025
The $746 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.79 · 2023: $252 · 2024: $869 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $442.61 | 2024-2025 | Injectafer |
| Pfizer INC. | $268.61 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $215.53 | 2024-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.37 | 2023-2025 | Lifevest |
| Myriad Women'S Health, INC. | $141.15 | 2023 | Myrisk |
| Medtronic, INC. | $134.52 | 2024 | Venaseal |
| Actelion Pharmaceuticals US, INC. | $119.30 | 2024 | Opsumit, Uptravi |
| Novo Nordisk INC | $100.70 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $81.69 | 2024-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.53 | 2024 | Jardiance |
| Baxter Healthcare | $34.22 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $30.48 | 2024 | Arcalyst |
| Boston Scientific Corporation | $24.31 | 2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $20.42 | 2024 | Xarelto |
| Amgen INC. | $20.00 | 2025 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $17.86 | 2025 | Nexletol |
| Therapeuticsmd, INC. | $15.79 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $13.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harpreet Sheller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.